FOGLI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 6.579
EU - Europa 3.610
AS - Asia 1.042
AF - Africa 147
OC - Oceania 30
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.438
Nazione #
US - Stati Uniti d'America 6.388
IT - Italia 1.230
SE - Svezia 628
DE - Germania 583
CN - Cina 490
BG - Bulgaria 282
GB - Regno Unito 244
CA - Canada 169
TR - Turchia 126
AT - Austria 123
VN - Vietnam 112
SG - Singapore 98
FI - Finlandia 90
IN - India 83
CI - Costa d'Avorio 81
FR - Francia 69
UA - Ucraina 67
PL - Polonia 55
RU - Federazione Russa 51
GR - Grecia 47
HK - Hong Kong 37
SN - Senegal 36
CH - Svizzera 35
BE - Belgio 33
AU - Australia 28
IR - Iran 22
MX - Messico 18
NG - Nigeria 18
ES - Italia 16
IL - Israele 16
JP - Giappone 16
BR - Brasile 15
RO - Romania 15
ID - Indonesia 11
PT - Portogallo 10
RS - Serbia 9
NL - Olanda 7
CO - Colombia 6
EG - Egitto 6
KR - Corea 6
TW - Taiwan 6
MA - Marocco 4
CL - Cile 3
DM - Dominica 3
HU - Ungheria 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IE - Irlanda 2
IQ - Iraq 2
LB - Libano 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 11.438
Città #
Woodbridge 1.048
Fairfield 702
Ann Arbor 604
Chandler 604
Houston 551
Ashburn 350
Serra 306
Sofia 282
Seattle 274
Wilmington 264
Cambridge 213
Milan 188
New York 182
Beijing 174
Ottawa 154
Princeton 144
Lawrence 119
Vienna 116
Pisa 109
Izmir 105
Medford 105
Jacksonville 94
Nanjing 85
Abidjan 81
Florence 81
Dearborn 67
London 62
Des Moines 61
Dong Ket 54
Redwood City 54
Rome 53
Frankfurt am Main 49
Warsaw 43
Lancaster 39
Dakar 36
Marseille 35
Bern 33
Hong Kong 33
Nanchang 33
San Diego 32
Jüchen 25
Falls Church 24
Bremen 22
Brussels 22
Kunming 22
Hefei 21
Nürnberg 20
Pune 20
Changsha 19
Tianjin 19
Lagos 18
Ogden 17
Norwalk 15
Pistoia 14
Hebei 13
San Francisco 13
Los Angeles 12
Naples 12
Shenyang 12
Auburn Hills 11
Boulder 11
Livorno 11
Lucca 11
Tel Aviv 11
Washington 11
Chaumont-gistoux 10
Guangzhou 10
Jiaxing 10
Phoenix 10
Shanghai 10
Jinan 9
Leawood 9
Boardman 8
Bucharest 8
Mumbai 8
Seacroft 8
Toronto 8
Braga 7
Chengdu 7
Delhi 7
Panorama City 7
Chicago 6
Favria 6
Merrick 6
Mexico 6
Morwell 6
Poitiers 6
Wuhan 6
Birmingham 5
Brisbane 5
Cascina 5
Düsseldorf 5
Gallicano 5
Jakarta 5
Osaka 5
Prato 5
Sydney 5
Trieste 5
Vellore 5
Absecon 4
Totale 8.262
Nome #
The molecular bases of cannabinoid action in cancer 255
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 253
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 205
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells 202
Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis 195
Sucrosomial iron and traditional iron dosage forms are compared for absorption by Caco2 cells. 191
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 189
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism 170
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 164
A flexible SNP genotyping system to study allelic determinants of brain function. 161
Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules 152
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 151
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 145
Survivin-directed molecular beacon as potential theranostic agent in melanoma cells 144
Anticancer activity of anandamide in human cutaneous melanoma cells 141
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 140
Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells 138
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 137
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 136
Rosiglitazone reverses salbutamol-induced ß(2) -adrenoceptor tolerance in airway smooth muscle. 133
Detection and silencing of survivin mRNA by bi-color imaging based on PMMA nanoparticles/molecular beacon in human cancer cells 132
Chronic administration of suramin induces neurotoxicity in rats 131
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 128
Survivin directed molecular beacon as potential “theranostic agent” in melanoma cells 127
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives 126
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. 123
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 121
Antiproliferative effects of Echinacea root hexanic extracts on Mia Paca-2 cells 121
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer 121
Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines 121
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 120
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 120
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 120
Survivin mRNA detection and silencing by a Molecular Beacon Oligodeoxynucleotide in living cutaneous melanoma cells 119
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 117
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli. 113
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. 113
Theranostic properties of a survivin-directed molecular beacon in human melanoma cells 113
Cannabinoid derivatives induce cell death in MIA Paca-2 cell line via a receptor-indipendent mechanism 112
A flexible SNP genotyping system to study allelic determinants of brain function 111
Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles 110
null 110
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 110
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 109
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 108
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 107
Montelukast reverses albuterol-induced b2-adrenoceptor tolerance in airway smooth muscle 106
Clinical pharmacology of intravitreal anti-VEGF drugs 106
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 105
Pathophysiology and pharmacological targets of VEGF in diabetic macular edema 104
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 102
Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents. 102
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 102
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 101
Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 101
Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells 100
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. 97
null 96
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells 95
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 95
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 94
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs 93
Potential relationship between the expression of Cx26/Cx43 and the BRAF mutation status in human melanoma cells 93
Identification of five circulating microRNAs with high diagnostic values in cutaneous melanoma 92
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 92
Farmacogenetica nelle neoplasie gastriche 91
Sucrosomial® iron absorption studied by in vitro and ex-vivo models 90
Influence of polysaccharides on expression of membrane-associated muc1 in cultivated epithelial cells 89
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 87
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 87
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens 87
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 87
null 85
null 84
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 83
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 81
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 81
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage 80
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 80
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer 79
In vitro investigation of sulindac derivatives as potential anticancer agents 78
In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: Implications for asthma 78
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 75
New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration 74
Cross-Linked Hyaluronic Acid as Tear Film Substitute 69
Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer 66
Evaluation of circulating microRNAs as diagnostic circulating biomarkers in cutaneous melanoma 65
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 63
ErbB in NSCLC as a molecular target: Current evidences and future directions 63
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 62
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 61
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 61
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer 59
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 58
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 58
Control of cell growth by ceramide analogues: a new strategy for anticancer drug development 57
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 57
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 56
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 54
Inhibition of RhoA activation in human bronchial smooth muscle cells: novel insights into the molecular mechanism of salbutamol action 52
Totale 10.878
Categoria #
all - tutte 29.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019688 0 0 0 0 0 0 0 0 0 242 267 179
2019/20202.151 238 166 139 127 194 318 225 178 182 160 173 51
2020/20211.088 79 71 57 78 103 67 67 94 135 116 78 143
2021/20221.479 43 77 65 90 233 212 60 70 63 49 86 431
2022/20232.062 257 292 162 169 194 278 37 152 371 10 126 14
2023/20241.139 142 163 158 83 176 252 71 52 29 13 0 0
Totale 11.796